English
Polski
Español
українська
Systemic complications influencing survival in cirrhosis
What are the most important systemic complications influencing the survival of patients with cirrhosis?
2018-03-14
What are the most important systemic complications influencing the survival of patients with cirrhosis?
It has already been several years since the wide adoption of new oral anticoagulants, such as dabigatran or rivaroxaban. Are we able to estimate how it has influenced the rate of gastrointestinal bleeding (GI) worldwide?
After the publication of the Kyoto global consensus report, we are faced with a new entity called Helicobacter pylori-associated dyspepsia. How to make an appropriate diagnosis of this condition?
What are the new technological advancements in the treatment of gastrointestinal bleeding?
What is the current knowledge on cyst fluid biomarkers? Do they play any role in practice?
Assuming a general practitioner’s perspective, could you define the key features of incidental pancreatic cystic lesions that warrant watchful waiting and those that require surgical treatment?
What should be our goal when treating patients with celiac disease? Is it the absence of villous atrophy or normalization of intraepithelial lymphocytes count?
What is the role of 24-hour pH-metry in patients with atypical gastroesophageal reflux disease (GERD) and in those with classic GERD? At what stage of diagnostic workup should pH-metry be performed?
How should we monitor mucosal healing in patients with celiac disease?
What findings in history or physical examination in a patient with laryngitis or chronic cough should raise the suspicion of gastroesophageal reflux disease (GERD)?
